ReviewExpert opinion on therapeutic targets2010

Cyclin-dependent kinases (cdks) and the DNA damage response: rationale for cdk inhibitor-chemotherapy combinations as an anticancer strategy for solid tumors.

Neil Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.